Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Premixed glucagon/insulin solution for faster insulin absorption in Type 1 diabetes
2023-510408-32-02Phase 2Suspended
- Sponsor
- St. Olavs University Hospital
- Start
- Jan 2025
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 2 trial of insulin lispro and glucagon in diabetes mellitus type 1 (T1D), sponsored by St. Olavs University Hospital. Primary endpoint: Area under the glucose consumption curve and area under the insulin curve for the first 30 minutes. Started Jan 2025; status: suspended.
02
Drugs
insulin lisproglucagon
03
Conditions
diabetes mellitus type 1 (T1D)
Beyond the preview
Go deeper on 2023-510408-32-02.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2023-510408-32-02.